209 related articles for article (PubMed ID: 16621549)
1. Novel 5-azaindole factor VIIa inhibitors.
Riggs JR; Hu H; Kolesnikov A; Leahy EM; Wesson KE; Shrader WD; Vijaykumar D; Wahl TA; Tong Z; Sprengeler PA; Green MJ; Yu C; Katz BA; Sanford E; Nguyen M; Cabuslay R; Young WB
Bioorg Med Chem Lett; 2006 Jun; 16(12):3197-200. PubMed ID: 16621549
[TBL] [Abstract][Full Text] [Related]
2. Potent 4-amino-5-azaindole factor VIIa inhibitors.
Hu H; Kolesnikov A; Riggs JR; Wesson KE; Stephens R; Leahy EM; Shrader WD; Sprengeler PA; Green MJ; Sanford E; Nguyen M; Gjerstad E; Cabuslay R; Young WB
Bioorg Med Chem Lett; 2006 Sep; 16(17):4567-70. PubMed ID: 16793264
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.
Wang T; Duffy JP; Wang J; Halas S; Salituro FG; Pierce AC; Zuccola HJ; Black JR; Hogan JK; Jepson S; Shlyakter D; Mahajan S; Gu Y; Hoock T; Wood M; Furey BF; Frantz JD; Dauffenbach LM; Germann UA; Fan B; Namchuk M; Bennani YL; Ledeboer MW
J Med Chem; 2009 Dec; 52(24):7938-41. PubMed ID: 20014869
[TBL] [Abstract][Full Text] [Related]
5. Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand.
Choi-Sledeski YM; Kearney R; Poli G; Pauls H; Gardner C; Gong Y; Becker M; Davis R; Spada A; Liang G; Chu V; Brown K; Collussi D; Leadley R; Rebello S; Moxey P; Morgan S; Bentley R; Kasiewski C; Maignan S; Guilloteau JP; Mikol V
J Med Chem; 2003 Feb; 46(5):681-4. PubMed ID: 12593648
[TBL] [Abstract][Full Text] [Related]
6. Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.
Al-awar RS; Ray JE; Hecker KA; Joseph S; Huang J; Shih C; Brooks HB; Spencer CD; Watkins SA; Schultz RM; Considine EL; Faul MM; Sullivan KA; Kolis SP; Carr MA; Zhang F
Bioorg Med Chem Lett; 2004 Aug; 14(15):3925-8. PubMed ID: 15225699
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitors.
Frohn M; Viswanadhan V; Pickrell AJ; Golden JE; Muller KM; Bürli RW; Biddlecome G; Yoder SC; Rogers N; Dao JH; Hungate R; Allen JR
Bioorg Med Chem Lett; 2008 Sep; 18(18):5023-6. PubMed ID: 18755588
[TBL] [Abstract][Full Text] [Related]
8. N-substituted azaindoles as potent inhibitors of Cdc7 kinase.
Bryan MC; Falsey JR; Frohn M; Reichelt A; Yao G; Bartberger MD; Bailis JM; Zalameda L; Miguel TS; Doherty EM; Allen JG
Bioorg Med Chem Lett; 2013 Apr; 23(7):2056-60. PubMed ID: 23481650
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
[TBL] [Abstract][Full Text] [Related]
10. Solvent-dependent oxidations of 5- and 6-azaindoles to trioxopyrrolopyridines and functionalised azaindoles.
Mahiout Z; Lomberget T; Goncalves S; Barret R
Org Biomol Chem; 2008 Apr; 6(8):1364-76. PubMed ID: 18385843
[TBL] [Abstract][Full Text] [Related]
11. 1,2-Disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors.
Takeuchi K; Bastian JA; Gifford-Moore DS; Harper RW; Miller SC; Mullaney JT; Sall DJ; Smith GF; Zhang M; Fisher MJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2347-51. PubMed ID: 11055353
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel heterocyclic factor VIIa inhibitors.
Rai R; Kolesnikov A; Sprengeler PA; Torkelson S; Ton T; Katz BA; Yu C; Hendrix J; Shrader WD; Stephens R; Cabuslay R; Sanford E; Young WB
Bioorg Med Chem Lett; 2006 Apr; 16(8):2270-3. PubMed ID: 16460932
[TBL] [Abstract][Full Text] [Related]
13. Organometallic methods for the synthesis and functionalization of azaindoles.
Song JJ; Reeves JT; Gallou F; Tan Z; Yee NK; Senanayake CH
Chem Soc Rev; 2007 Jul; 36(7):1120-32. PubMed ID: 17576479
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors.
Parlow JJ; Kurumbail RG; Stegeman RA; Stevens AM; Stallings WC; South MS
J Med Chem; 2003 Oct; 46(22):4696-701. PubMed ID: 14561089
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 4-azaindoles as novel inhibitors of c-Met kinase.
Porter J; Lumb S; Franklin RJ; Gascon-Simorte JM; Calmiano M; Riche KL; Lallemand B; Keyaerts J; Edwards H; Maloney A; Delgado J; King L; Foley A; Lecomte F; Reuberson J; Meier C; Batchelor M
Bioorg Med Chem Lett; 2009 May; 19(10):2780-4. PubMed ID: 19369077
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of the first all-aza analogue of a biologically active peptide.
Gante J; Krug M; Lauterbach G; Weitzel R; Hiller W
J Pept Sci; 1995; 1(3):201-6. PubMed ID: 9222997
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.
Parlow JJ; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(20):4297-312. PubMed ID: 13678408
[TBL] [Abstract][Full Text] [Related]
19. Dysinosins B-D, inhibitors of factor VIIa and thrombin from the Australian sponge Lamellodysidea chlorea.
Carroll AR; Buchanan MS; Edser A; Hyde E; Simpson M; Quinn RJ
J Nat Prod; 2004 Aug; 67(8):1291-4. PubMed ID: 15332844
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition.
Klingler O; Matter H; Schudok M; Donghi M; Czech J; Lorenz M; Nestler HP; Szillat H; Schreuder H
Bioorg Med Chem Lett; 2004 Jul; 14(14):3715-20. PubMed ID: 15203149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
